Wave Life Sciences to Webcast Conference Call of Fourth Quarter and Full Year 2020 Financial Results on March 4, 2021
24 February 2021 - 12:00AM
Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic
medicines company committed to delivering life-changing treatments
for people battling devastating diseases, announced today that
management will host a live webcast and conference call at 8:00
a.m. ET on Thursday, March 4, 2021, to discuss its fourth quarter
and full year 2020 financial results and provide a business update.
The webcast of the conference call may be accessed by visiting
the “Events” section in the Investor Relations page of the Wave
Life Sciences website at www.wavelifesciences.com. The live
teleconference may be accessed by dialing (866) 220-8068 (domestic)
or (470) 495-9153 (international) and entering conference ID:
6269069. Following the conference call, an archived version of the
call will be available on the website.
About Wave Life Sciences Wave Life Sciences
(Nasdaq: WVE) is a clinical-stage genetic medicines company
committed to delivering life-changing treatments for people
battling devastating diseases. Wave aspires to develop
best-in-class medicines across multiple therapeutic modalities
using PRISM, the company’s proprietary discovery and drug
development platform that enables the precise design, optimization
and production of stereopure oligonucleotides. Driven by a resolute
sense of urgency, the Wave team is targeting a broad range of
genetically defined diseases so that patients and families may
realize a brighter future. To find out more, please visit
www.wavelifesciences.com and follow Wave on Twitter
@WaveLifeSci.
Investor Contact:Kate
Rausch617-949-4827krausch@wavelifesci.com
Media Contact:Alicia
Suter617-949-4817asuter@wavelifesci.com
Wave Life Sciences (NASDAQ:WVE)
Historical Stock Chart
From Apr 2024 to May 2024
Wave Life Sciences (NASDAQ:WVE)
Historical Stock Chart
From May 2023 to May 2024